by editor | Mar 7, 2014 | Clinicians, Participants
ASPREE PI editorial in this week’s ‘Medical Observer’ ASPREE Principal Investigator in Australia, Professor John McNeil discusses what the findings of ASPREE trial may mean to future health care. “Currently, it is not known if low-grade inflammation is...
by editor | Feb 2, 2014 | Clinicians, Participants, Researchers
A run-down of an amazing year for the ASPREE Clinical Trial In 2013, we reached a number of significant milestones that could not have been reached without the generosity of older Australians, supporting GPs and practice staff and our hard-working team....
by editor | Nov 27, 2013 | Clinicians, Participants
Fantastic to meet so many of our participants and guests at ASPREE study updates in parts of south-eastern Australia in the second half of this year ASPREE’s Executive Officer, A/Prof Robyn Woods presented in Melbourne and regional Victoria; Prof Mark...
by editor | Oct 3, 2013 | Clinicians, Participants, Researchers
ANNOUNCEMENT Wollongong locals to participate in Australia’s largest primary prevention Aspirin trial Above: From left, ASPREE Principal Investigator, Prof John McNeil, ASPREE Wollongong Study Co-ordinator, Ros Whitaker and Prof Wilf Yeo, Director of Clinical...
by editor | Aug 30, 2013 | Clinicians, Participants
The trial to answer important aspirin question Sapphire Coast GP, Dr Duncan Mackinnon, told a journalist in an interview for the Bega District News, that ASPREE would give GPs answers to questions about daily low-dose aspirin in healthy older adults....
Recent Comments